SS
ACET icon

Steve Schonfeld’s Adicet Bio ACET Stock Holding History

Steve Schonfeld’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Buy
+195,514
New +$1.54M 0.01% 1162
2025
Q4 		– Sell
-29,944
Closed -$388K – 1994
2025
Q3 		$388K Sell
29,944
-87,562
-75% -$1.03M ﹤0.01% 1762
2025
Q2 		$1.15M Buy
+117,506
New +$1.24M 0.01% 1245
2024
Q3 		– Sell
-1,850
Closed -$35.8K – 1994
2024
Q2 		$35.8K Sell
1,850
-69,050
-97% -$1.85M ﹤0.01% 1966
2024
Q1 		$2.67M Buy
70,900
+58,394
+467% +$2.42M 0.02% 892
2023
Q4 		$378K Buy
+12,506
New +$273K ﹤0.01% 1366
2023
Q3 		– Sell
-1,081
Closed -$42K – 1719
2023
Q2 		$42K Buy
+1,081
New +$95.4K ﹤0.01% 1831

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Steve Schonfeld's ACET Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Adicet Bio (ACET) in Q2 2026: 195,514 shares worth $1.69M. The stake represents 0.01% of the portfolio and ranks #1162 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in ACET as recently as Q3 2025.

Steve Schonfeld first reported a position in ACET in Q2 2023 and has held it in 7 quarters since. The position peaked at $2.67M in Q1 2024. 56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

  • Steve Schonfeld held 195,514 shares of Adicet Bio worth $1.69M as of Q2 2026.
  • Adicet Bio was a new Steve Schonfeld position in Q2 2026.
  • Adicet Bio made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1162 holding.
  • Steve Schonfeld first reported a position in Adicet Bio in Q2 2023 and has held it in 7 quarters since.
  • Steve Schonfeld's Adicet Bio position peaked at $2.67M in Q1 2024.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.